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Abstract The FtsH (HflB) protein of Escherichia coli is a
membrane-bound ATP-dependent zinc protease. The role(s) of
the N-terminal membrane-anchoring region of FtsH were studied
by fusion with a maltose-binding protein (MBP) at five different
N-termini of FtsH. The MBP-FtsH fusions were expressed in the
cytoplasm of E. coli, and were purified as soluble proteins. The
four longer constructs, which have a second transmembrane
segment and the C-terminal cytoplasmic region in common,
retained ATP-dependent protease activity toward heat-shock
transcription factor c32, and were found to be homo-oligomers.
In contrast, the shortest construct which has the C-terminal
cytoplasmic region but not the second transmembrane segment
showed neither protease activity nor oligomerization. Therefore,
the second transmembrane segment, which neighbors the C-
terminal cytoplasmic region of the FtsH, participates in not only
its membrane-anchoring, but also its protease activity and homo-
oligomerization.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
In Escherichia coli, some ATP-dependent proteases, such as
Lon [1], ClpAP [2], ClpXP [3,4], HslUV [5], and FtsH [6], are
known. Among them, only FtsH is a membrane-bound ATP-
dependent protease [6,7], and is essential for cell growth [8].
FtsH belongs to the AAA (ATPases associated with a variety
of cellular activities) protein family [9], whose members are
widely found in various organisms. The members have con-
served 200 amino acid modules, which are called AAA mod-
ules. They are associated with diverse cellular functions, such
as cell cycle control, protein degradation, transcriptional reg-
ulation, protein secretion, and the biogenesis of organelles
[10]. FtsH seems to have to do with various cellular functions.
The phenotypes of ftsH mutants are temperature-sensitive
growth (Ts3) [11], a high frequency of lysogenization (H£3)
[12], a stop-transfer defect (Std3) [8], and mRNA stabilization
[13]. Also, more severe ftsH mutants, tolZ (except for tolZ10
and tolZ60 [14]) and vftsH, require suppressor mutation(s) for
survival [14,15], and show pleiotropic phenotypes, i.e. colicin
tolerance (Tol3) and no growth on succinate or other non-
fermentable carbon sources (Nfc3), as well as Ts3, H£3 and
Std3 [16,17].
FtsH consists of a membrane-anchoring region (amino
acids 1 to 123) in the N-terminus and a cytoplasmic region
(amino acids 124 to 647) in the C-terminus [7]. The mem-
brane-anchoring region consists of two transmembrane seg-
ments and a periplasmic region in between. The membrane-
anchoring region participates in homo-oligomerization [18],
especially the periplasmic region [19]. The cytoplasmic region
includes active-site motifs for ATPase and zinc-dependent
protease. FtsH degrades several membrane proteins, such as
the uncomplexed SecY protein [20,21], unassembled subunit a
of the proton ATPase F0 sector [22], and YccA [23], and also
degrades several cytoplasmic proteins, heat-shock transcrip-
tion factor c32 [6,24], Vphage cII [12] and cIII [25], and
some mutant form of the Vphage cI [26]. The puri¢ed FtsH
protein was found to degrade its substrates in an ATP-de-
pendent manner in in vitro experiments [6,21,26].
To determine further the biochemical characteristics of
FtsH in vitro, we previously puri¢ed a soluble form of FtsH
which has only the cytoplasmic C-terminal region, there was
little or no protease activity (unpublished data). Therefore, we
assumed that the membrane-anchoring region might be in-
volved in the expression of the protease activity, and con-
structed fused proteins of maltose-binding protein (MBP)
with truncated FtsH. We investigated the e¡ect of truncation
of the N-terminal membrane-anchoring region on the ATPase
and protease activities, and the oligomerization of the fused
proteins.
2. Materials and methods
2.1. Bacterial strain and DNA manipulation
The E. coli K-12 strain used in this study was JM109 [recA1, endA1,
gyrA96, hsdR17, supE44, relA1,v(lac-proAB)/FP traD36, proAB, lacq,
lacZvM15] [27]. The recombinant DNA techniques were essentially as
described [28]. DNA sequencing was performed by the dideoxynucleo-
tide termination method with an Applied Biosystems DNA sequencer
(model 310).
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2.2. Plasmids
The plasmid, pJN340, which has a 1.8-kb BamHI fragment con-
taining the ftsH gene [16], was digested with EcoRI and PstI, and then
the fragment was inserted into the cloning site of pMAL-c2 (New
England Biolabs, Inc), which had been digested with EcoRI and
PstI, giving pMFC0. This pMFC0 plasmid codes for only MBP since
FtsH is not in-frame. An EcoRI site was introduced into pAR145R
[14] to make pM1, and pJN340 to make pM4 and pM5, by means of a




3P (EcoRI site is underlined), with each complementary oligonucleo-
tide, respectively. The three resultant plasmids, pM1, pM4 and pM5,
were cut with ClaI and EcoRI, and then the fragments were inserted
into the corresponding sites of pMFC0, giving pMFC1, pMFC4 and
pMFC5, respectively. pAR145R was digested with ApaI, ¢lled-in with
Klenow enzyme, and then digested with ClaI. This ApaI (¢lled-in)-
ClaI fragment was inserted into pMFC0, which had been digested
with EcoRI (¢lled-in) and ClaI, giving pMFC2. pJN340 was digested
with PstI and SacI, and then treated with Klenow enzyme to make a
blunt end. This blunt-ended PstI-SacI fragment was ligated into the
blunt-ended PstI site of pMAL-c2, giving pMFC3. The cloned frag-
ment was con¢rmed to have no unexpected mutations by DNA se-
quencing.
2.3. Puri¢cation of MBP-FtsHs
E. coli JM109 cells harboring a recombinant plasmid were cultured
at 37‡C in 0.2 l of LB medium (1% Bacto tryptone, 0.5% Bacto yeast
extract and 0.5% NaCl, adjusted with NaOH to pH 7.0) containing
ampicillin (100 Wg/ml) with a 1% inoculum of an overnight culture,
and then induced by the addition of 0.3 mM IPTG at A660 = 1 for 1 h.
The cells were collected by centrifugation, and then washed with 20
mM Tris-HCl bu¡er (pH 8.0) containing 200 mM NaCl and 10 mM
2-mercaptoethanol. The washed cells were suspended in 20 ml of the
same bu¡er containing 1 mM phenylmethanesulfonyl £uoride, and
then disrupted by sonication. The sonicated sample was centrifuged
at 4000Ug for 40 min. The supernatant was applied to an amylose
resin column (3 ml) equilibrated with the same bu¡er. After washing
the column with the same bu¡er, the enzyme was eluted with the same
bu¡er containing 10 mM maltose. The eluate was concentrated by
ultra¢ltration using Ultrafree-15 (Millipore Corp.), exchanging the
bu¡er with 20 mM Tris-HCl bu¡er (pH 8.0) containing 200 mM
NaCl, 10 mM 2-mercaptoethanol and 1 mM maltose. The protein
concentrations were measured with the Bio-Rad protein assay reagent
(Bio-Rad Laboratories), with bovine Q-globulin as a standard.
2.4. Assay for ATPase activity
The assay for ATPase activity was carried out according to the
method of Akiyama et al. [21], except that the assays were performed
without a detergent.
2.5. Assay for proteolytic activity toward c32-C-his
c32-C-his was puri¢ed as described previously [29], and used as a
substrate for MBP-FtsH proteins. The reaction for the proteolytic
activity was performed essentially as described by Tomoyasu et al.
[6] with some modi¢cations. The complete reaction mixture (50 Wl)
consisted of the following: 50 mM Tris-acetate (pH 8.0), 5 mM mag-
nesium acetate, 12.5 WM zinc acetate, 20 mM KCl, 100 mM NaCl,
2 mM 2-mercaptoethanol, 4 mM ATP, 2 Wg of BSA, 3.26 Wg of the
puri¢ed MBP-FtsH, and 4 Wg of puri¢ed c32-C-his (the molar ratio of
MF1 and c32-C-his being 1:7). Reactions were performed at 42‡C.
Portions (4 Wl) of the reaction mixtures were subjected to SDS-PAGE
on 12% polyacrylamide gels [30], and then stained with Coomassie
brilliant blue.
2.6. Analytical ultracentrifugation
Sedimentation velocity experiments were performed with a Beck-
man Optima XLA analytical ultracentrifuge equipped with absorb-
ance optics and an An50Ti rotor. The experiments were performed
at 4‡C and 30 000 rpm with protein concentrations of 1.04, 1.50, 1.63,
1.45 and 1.56 mg/ml, for MF1 to MF5, respectively, ranging in OD280
from 0.8 to 1.0. The data were collected at 280 nm and at a spacing of
0.003 cm in the continuous scan mode. The data were analyzed with
DCDT software to determine the distribution of sedimentation coef-
¢cients, g*(s), using the di¡erences of absorbance pro¢les at successive
times averaged over many di¡erences [31].
2.7. Circular dichroism spectroscopy
Circular dichroism spectra were acquired with a Jasco Model 720
spectropolarimeter. Samples were prepared in 10 mM potassium
phosphate (pH 8.0) with a protein concentration of 60 Wg/ml. For
helix content determination, the Protein Secondary Structure Estima-
tion Program (Jasco, Japan) was used. This program is based on the
method described by Yang et al. [32].
3. Results
3.1. Puri¢cation of MBP-FtsH fusions
Five MBP-FtsH fusions (MFs), named MF1 to MF5 (Fig.
1), were puri¢ed as soluble enzymes in a single step on an
amylose resin column. On SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE) (Fig. 2), their polypeptide sizes corre-
sponded well to those calculated from the coding sequence;
113 kDa, 110 kDa, 106 kDa, 102 kDa, and 99 kDa, for MF1
to MF5, respectively. We puri¢ed the MFs to more than 80%
homogeneity, which was determined by densitometric scan-
ning of a Coomassie brilliant blue-stained SDS-PAGE gel
(Fig. 2). We assume that major contaminants are partially
degraded MFs, because anti-FtsH reacted with the bands be-
low the main bands on Western blotting (data not shown).
3.2. ATPase activity
All MFs retained ATPase activity (Table 1). The ATPase
activity of MF1 was similar to that of intact FtsH [6] or FtsH-
His6-Myc [21] when compared per mole of protein. MF2 to
Fig. 1. Schematic representation of FtsH and the MBP-FtsH fusions
(MFs). The MBP region is presented as a hatched box. Two mem-
brane-spanning segments of FtsH are shown as ¢lled boxes. Each
fused point between MBP and FtsH is indicated as the number of
amino acid residues from the N-terminus of FtsH.
Table 1
ATPase activities of the MBP-FtsHs
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MF4 showed reduced ATPase activity to some extent. MF5
showed rather low ATPase activity.
3.3. Degradation of c32-C-his
The four relatively large MFs, MF1 to MF4, degraded c32-
C-his equally (Fig. 3). In contrast, MF5, which possesses only
the cytoplasmic region, showed no proteolytic activity (Fig.
3). In the absence of ATP, none of the MFs degraded c32-C-
his (data not shown). These results indicate the requirement of
the second transmembrane segment for their proteolysis of
c32-C-his. As can be seen in Fig. 3, the MFs having protease
activity degraded c32-C-his without detectable intermediates.
3.4. Homo-oligomerization observed on analytical
ultracentrifugation
To determine whether or not the MFs are in a homo-oligo-
meric state, all the puri¢ed proteins were subjected to sedi-
mentation velocity analyses. g*(s) analysis showed a clear dif-
ference of MF5 from the others (Fig. 4). MF5 was supposed
to be in a monomeric state since the molecular mass calcu-
lated from the roughly estimated sedimentation coe⁄cient and
di¡usion coe⁄cient was smaller than the size of a single poly-
peptide chain (data not shown). All the other four proteins,
i.e. MF1 to MF4, formed large complexes with peaks from 12
S to 20 S. Faster sedimenting minor fraction seen as the peaks
around 35 S would be an aggregated product for its very large
size and a small amount, considering from the report [33] of
the tendency for FtsH-His6-Myc to aggregate without ATP at
37‡C. For the polydispersity and instability of MFs even in
the storage at 4‡C, we could not hold sedimentation equilib-
rium analysis to obtain accurate molecular masses.
3.5. Determination of secondary structure components
The estimated K-helix contents of the MFs and MBP on
circular dichroism spectroscopy are shown in Table 2. For
MBP, the K-helix content was in good agreement with that
of the known three-dimensional structure [34]. For the MFs,
the K-helix contents which originate from FtsH portion were
also calculated (Table 2). All MFs had similar K-helix con-
tents. This suggests that the loss of activity seen for MF5 is
not due to a destruction of the secondary structure.
4. Discussion
ATP-dependent proteolytic systems have been widely
found, and are probably essential for cells to survive. In eu-
karyotes, the 26 S proteasome is a major ATP-dependent
protease, which consists of a number of proteins [35]. In E.
coli, ATP-dependent proteases known so far, such as ClpAP
[2], ClpXP [3,4], HslVU [5], Lon [1], and FtsH [6], each form a
multimeric enzyme [2,18,36,37]. For example, HslVU consists
of two di¡erent multimeric components, HslV and HslU.
HslU ( = ClpY) is the ATPase component, which belongs to
the ClpY subfamily of the Clp family, and HslV is the pro-
tease component, which exhibits similarity to the L-type sub-
unit of the 20 S proteasome [36]. Mutational analysis of HslU
in the ATP-binding site revealed a functional relationship
among ATP-binding, oligomerization, and peptide hydrolysis
[38]. In the case of FtsH, mutations in the ATP-binding site
reducing the ATPase activity a¡ected the protease activity at
Fig. 2. SDS-PAGE of MFs. The proteins were fractionated by
SDS-PAGE on a 12% polyacrylamide gel and then stained with
Coomassie brilliant blue. M, the leftmost lane, indicates molecular
mass markers.
Fig. 3. Proteolysis of c32-C-his by MFs. Samples were analyzed by
SDS-PAGE on a 12% polyacrylamide gel and then stained with
Coomassie brilliant blue. The incubation times are indicated in the
¢gure. M, the leftmost lane, indicates molecular mass markers.
Fig. 4. Sedimentation coe⁄cient distribution, g*(s), analyses of
MFs. MF1 (thin line), MF2 (dashed line), MF3 (dotted line), MF4
(dot-dash line), and MF5 (thick line) were subjected to sedimenta-
tion velocity experiments as described in Section 2. The g*(s) plots
were generated as described in Section 2 using DCDT software.
Table 2
K-Helix contents of the MBP-FtsHs and MBP
Construct K-Helix content
(%)









S. Makino et al./FEBS Letters 460 (1999) 554^558556
the same time [21]. This implies the inseparability of a pro-
tease domain from an ATPase domain. Therefore, we suppose
FtsH has an ATP-dependent protease domain.
The N-terminal transmembrane region is involved in the
formation of a complex of FtsH in the cytoplasmic membrane
[18], and FtsH solubilized with a non-ionic detergent can also
be cross-linked to form an oligomeric structure [18], suggest-
ing that FtsH molecules directly interact with each other.
Moreover, the molecular mass was estimated to be about
1000 kDa on gel ¢ltration chromatography of FtsH-His6-
Myc [19]. Recently, it was reported that the periplasmic region
plays crucial roles in protein-protein interactions and modu-
lates proteolytic functions [19].
In this study, ¢ve MBP-FtsH fusions, named MF1 to MF5,
were constructed so as to have the full (MF1), partial (MF2 to
MF4) or no (MF5) transmembrane region. We could obtain
all the MFs as soluble enzymes without a detergent. The ad-
dition of MBP might increase solubility and inhibit membrane
insertion. Probably transmembrane segments may interact
with each other to minimize hydrophobic surface. The MFs
having a second transmembrane segment, MF1 to MF4,
formed homo-oligomers and showed ATP-dependent proteo-
lytic activity toward c32-C-his. Such characteristics are the
same as those of FtsH puri¢ed from membranes with a de-
tergent [6]. Although MBP is known to form a dimer, we
included the ligand, maltose, in the enzyme solution to pre-
vent the dimerization of the MBP portion, for it is known that
maltose provokes monomerization [39].
As for the ATP-dependent proteolysis of c32-C-his, the sec-
ond transmembrane segment and the C-terminal cytoplasmic
region were necessary and su⁄cient. Therefore we assume
these constitute an ATP-dependent protease domain, and
the rest, mostly the periplasmic domain, probably participate
in its modulation. The ATPase activity of the MBP fusions
was a¡ected by the length of the retained N-terminal sequence
of FtsH. This could be evidence that the periplasmic domain
and the transmembrane segments participate in the modula-
tion of ATPase activity.
Through analogy with the other ATP-dependent proteases
[40], we suppose FtsH can interact with protein substrates and
that its chaperone-like activity is promoted as to the unfolding
or remodeling of substrates through ATP hydrolysis. At
present it is known that a denatured alkaline phosphatase
can associate with FtsH-His6-Myc [33]. Moreover, an ATP-
induced conformational change of FtsH-His6-Myc itself was
observed [33]. Our data suggested an intimate relationship
among ATPase activity, protease activity and oligomer for-
mation. Therefore we assume oligomer formation is needed
for the ATP-driven structural change or the ability to extend
substrate polypeptides. A recent study on Yme1, which is a
mitochondrial homolog of FtsH, revealed chaperone-like ac-
tivity for only its AAA domain [41], lacking a transmembrane
region. They noted its low substrate a⁄nity might be due to
insu⁄cient oligomerization. Here we showed that the second
transmembrane segment of FtsH was indispensable for its
proteolytic activity and its oligomerization.
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